Article Type
Review
Published
This narrative review explores new systemic therapies for psoriasis, including both approved and emerging biologics and small molecules, highlighting future directions in treatment.
Review
This narrative review explores new systemic therapies for psoriasis, including both approved and emerging biologics and small molecules, highlighting future directions in treatment.
Original Research
This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.
Original Research
This study aimed to evaluate the real-world efficacy and safety of brodalumab treatment in a Portuguese population.
Case Series
This article reports on a discussion between a group of experts regarding the value of the Cal/BD foam as a topical treatment for mild-to-moderate psoriasis in combination with systemic treatments. Experiences support effectiveness of the Cal/BD foam in daily clinical practice, with an improvement in patient quality of life.
Original Research
This multicentre study focuses on psoriasis affecting sensitive areas, its impact on quality of life and the therapeutic response to risankizumab.